![]() Initial tissue sampling was attempted by bronchoscopy, but the tissue obtained did not appear to accurately represent the cell population present. Differential diagnosis at this time included lymphoma versus sarcoidosis. Recommended follow-up PET-CT confirmed pathologically enlarged hypermetabolic lymph nodes in the neck, chest, and abdomen as well as hypermetabolic lymphoid tissue in the palatine tonsils and adenoid tissue. CT of the chest/abdomen/pelvis was obtained which showed hilar and mediastinal lymphadenopathy as well as unchanged hepatomegaly from May of 2019, but newly identified splenomegaly. Significant laboratory findings included a WBC of 10.9, AST 103, ALT 207, and an alkaline phosphatase of 354. On presentation vital signs were unremarkable except for patient’s blood pressure which was elevated at 172/82. She also reported associated subjective fever. Patient reported her pain was a 7/10 in intensity. Patient is a 26 year-old female with past medical history of chronic sinusitis, pre-diabetes mellitus, morbid obesity, depression, and anxiety who initially presented with left lower abdominal pain that radiated into her lower back. In this case report, we will discuss post-COVID lymphadenopathy in a 26 year-old female who was diagnosed with COVID-19, not requiring hospitalization, approximately 4 months prior to imaging findings. Speculation has arisen as to this finding being isolated to severe cases of the disease. While rare, lymphadenopathy, especially hilar lymphadenopathy, has been reported on CT imaging of COVID-19 patients. A more infrequent finding is lymphadenopathy. Common CT imaging findings include bilateral ground-glass opacities and peripheral air space opacities. To view this video please enable JavaScript, and consider upgrading to a web browser thatĬomputed tomography (CT) is an informative tool in the diagnosis of COVID-19.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |